US stem cell sponsor sees veto-proof Senate backing
By Susan Cornwell
WASHINGTON (Reuters) – An expansion of federally funded
embryonic stem cell research could pass the U.S. Senate with a
veto-proof margin now that the chamber’s leader backs the idea,
a leading sponsor of the effort said on Sunday.
But it may be harder getting the super-majority needed to
override a possible presidential veto in the House of
Representatives, Pennsylvania Republican Sen. Arlen Specter
Specter said the decision last week by Senate Majority
Leader Bill Frist to defy President Bush and support
legislation liberalizing the administration’s policy on stem
cell research had given the effort a “big boost” in Congress.
“I think we’re on our way,” Specter, co-sponsor of a bill
to expand the research, told CBS’s “Face the Nation.”
Bush, a Republican, has said he will veto any bill that
extends embryonic stem cell research beyond the limits he
imposed in 2001. The president is opposed because embryos are
destroyed when the stem cells are extracted.
Frist, a Tennessee Republican and heart surgeon who may
seek his party’s presidential nomination in 2008, broke with
Bush on Friday by endorsing a bill already passed by the House
– though not with a veto-proof margin — that would overturn
the limits Bush imposed four years ago.
Specter said the change of heart on stem cells by the
anti-abortion Frist gave political cover to lawmakers in both
houses of Congress who were considering the issue.
“My analysis is that we have 62 votes at the present time,
and we’ve got about 15 more people who are thinking it over. I
believe that by the time the vote comes up we’ll have 67,”
Specter said, referring to the two-thirds Senate majority
needed to override a presidential veto.
“I think our problem … is going to be to get it in the
House,” Specter added.
Separately, conservative Republican Sen. Rick Santorum said
he was convinced Bush would still veto the legislation, despite
the shifting politics on Capitol Hill.
“Without question the president will veto this,” Santorum,
the Senate’s third-ranking Republican, told ABC’s “This Week.”
“Obviously the majority of the House and majority of the
Senate disagree with him, but I’m hopeful the House will
continue to have the votes necessary to sustain this veto,”
said Santorum, who like Specter is from Pennsylvania.
The stem cell bill, likely to be brought up in the Senate
after the August recess, would allow federally funded research
on cells derived from leftover embryos in fertility clinics.
There are about 400,000 such frozen embryos, many of which will
otherwise be destroyed.
Patients suffering from diabetes, Parkinson’s disease,
spinal cord injuries and other life-threatening disorders have
been clamoring for more federal dollars for cell research.
Santorum warned that Frist’s decision could create problems
for him with the Republicans’ conservative base.
But Specter, a moderate Republican and cancer patient,
disagreed, adding that he didn’t think a presidential candidate
opposed to expanding stem cell research could be elected.
“I believe it will be helpful to him (Frist). You have an
enormous constituency out there — 110 million Americans,
directly or indirectly, are affected by Parkinson’s, cancer,
heart disease, etc,” Specter said.